review·Nature Reviews Drug Discovery·Dec 21, 2022BRONZE OA

Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation

RJRichard J. MeadCorresponding authorNSNing ShanHJH. Joseph ReiserFHFiona H. MarshallPJPamela J. Shaw

e-Therapeutics (United Kingdom) · University of Sheffield · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

463
total citations
FWCI
53.22
Percentile
100%
References
315
Citations per year

Authors

5
  • RJ
    Richard J. MeadCorresponding

    e-Therapeutics (United Kingdom), University of Sheffield

  • NS
    Ning Shan
  • HJ
    H. Joseph Reiser
  • FH
    Fiona H. Marshall

    MSD (UK) Limited (United Kingdom)

  • PJ
    Pamela J. Shaw

    e-Therapeutics (United Kingdom), University of Sheffield

Topics & keywords

Topics
  • Primary topicAmyotrophic Lateral Sclerosis Research100%
  • Neurogenetic and Muscular Disorders Research99%
  • Cholinesterase and Neurodegenerative Diseases98%
Keywords
  • Amyotrophic lateral sclerosis
  • Medicine
  • Disease
  • Neuroscience
  • SOD1
  • Drug discovery
  • Drug development
  • Drug
No related works found for this paper.

Funding

  • NI
    National Institute for Health and Care Research
    Awards: IS-BRC-1215, IS-BRC-1215-20017
  • MN
    Motor Neurone Disease Association
    Award: 974-797
  • MR
    Medical Research Council
    Award: MR/V027735/1
  • NS
    NIHR Sheffield Biomedical Research Centre
    Awards: IS-BRC-1215-20017, BRC-1215-20017